Company intelligence / Profile preview

Cellavent Healthcare

Düsseldorf, North Rhine-Westphalia, Germany

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Cellavent Healthcare is a leading German innovator in evidence-based nutritional supplements and plant-based health products. Their portfolio, currently commercial, leverages unique fermentation processes to enhance bioavailability and efficacy of botanicals (notably turmeric and olive oil), with some products achieving market leadership (e.g., Montmorency cherry extract) and published evidence of efficacy in gut health and anti-inflammatory support.[1][2]

Therapeutic areas: ImmunologyGastroenterologyInfectious DiseasesMetabolic DisordersOther
Modalities: NutraceuticalPlant extractFermented botanicalSmall moleculePeptidesPostbioticParaprobiotic
Industry: Food & Nutrition

Partnerships

Oncotrition (Fraunhofer spin-off, acquired 2018)LykonFermentlife

Beyond the preview

Go deeper on Cellavent Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellavent Healthcare.

Explore the full profile